Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

ABSTRACT:

Introduction

Retinal thickness measured with optical coherence tomography has been proposed as a noninvasive biomarker for Alzheimer's disease (AD). We therefore measured retinal thickness in well-characterized AD and control participants, considering ophthalmological confounders.

Methods

We included 57 amyloid-proven AD cases and 85 cognitively normal, amyloid-negative controls. All subjects underwent retinal thickness measurements with spectral domain optical coherence tomography and an ophthalmological assessment to exclude ocular disease.

Results

Retinal thickness did not discriminate cases from controls, including stratified analyses for early- versus late-onset AD. We found significant associations between macular thickness and global cortical atrophy [β -0.358;

SUBMITTER: den Haan J 

PROVIDER: S-EPMC6584766 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature